Platelet microparticles and cancer: An intimate cross-talk

Transfusion and Apheresis Science

Volumn 53, Issue 2, 2015, Pages 168-172

  Goubran, Hadi ^a   Sabry, Waleed ^a   Kotb, Rami ^b   Seghatchian, Jerard ^c   Burnouf, Thierry ^d  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c International Consultancy in Blood Components Quality Safety Improvement   (United Kingdom)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PROCOAGULANT;

BLOOD COMPONENT; CANCER CELL; CANCER GROWTH; CANCER PATIENT; HUMAN; IMMUNOSURVEILLANCE; MOLECULAR INTERACTION; NEOPLASM; NONHUMAN; PLATELET MICROPARTICLE; REVIEW; THROMBOSIS; TRANSFUSION; TUMOR GROWTH; ADVERSE EFFECTS; ANIMAL; BLOOD; BLOOD CLOTTING; MEMBRANE MICROPARTICLE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; THROMBOCYTE; THROMBOCYTE TRANSFUSION; TUMOR MICROENVIRONMENT;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PLATELET TRANSFUSION; THROMBOSIS; TUMOR MICROENVIRONMENT;

EID: 84951790216     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2015.10.014     Document Type: Review

References (59)

1. Varki A. Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 2007, 110:1723-1729.
2. Blom J., Vanderschoot J., Oostindier M., Osanto S., Van Der Meer F., Rosendaal F. Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study. J Thromb Haemost 2006, 4:529-535.
3. Neoptolemos J.P., Stocken D.D., Dunn J.A., Almond J., Beger H.G., Pederzoli P., et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001, 234:758.
4. Walker G., Xenophontos M., Chen L., Cheung K. Long-term efficacy and safety of exemestane in the treatment of breast cancer. Patient Prefer Adherence 2013, 7:245.
5. Sousou T., Khorana A.A. New insights into cancer-associated thrombosis. Arterioscler Thromb Vasc Biol 2009, 29:316-320.
6. Khorana A., Francis C., Menzies K., Wang J.G., Hyrien O., Hathcock J., et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 2008, 6:1983-1985.
7. van Doormaal F., Kleinjan A., Berckmans R., Mackman N., Manly D., Kamphuisen P.W., et al. Coagulation activation and microparticle-associated coagulant activity in cancer patients. Thromb Haemost 2012, 108:160-165.
8. Goubran H.A., Burnouf T., Radosevic M., El-Ekiaby M. The platelet-cancer loop. Eur J Intern Med 2013, 24:393-400.
9. Italiano Jr J.E., Mairuhu A.T., Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 2010, 17:578.
10. Zwaal R.F., Comfurius P., Bevers E.M. Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochim Biophys Acta 1992, 1180:1-8.
11. Freyssinet J.-M., Toti F. Formation of procoagulant microparticles and properties. Thromb Res 2010, 125:S46-8.
12. Jurasz P., Alonso-Escolano D., Radomski M.W. Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol 2004, 143:819-826.
13. Kedzierska M., Olas B., Wachowicz B., Stochmal A., Oleszek W., Jeziorski A., et al. An extract from berries of Aronia melanocarpa modulates the generation of superoxide anion radicals in blood platelets from breast cancer patients. Planta Med 2009, 75:1405-1409.
14. Mezouar S., Mege D., Darbousset R., Farge D., Debourdeau P., Dignat-George F., et al. Involvement of platelet-derived microparticles in tumor progression and thrombosis 2014, 346-358. Seminars in oncology: Elsevier.
15. Sims P., Wiedmer T. Repolarization of the membrane potential of blood platelets after complement damage: evidence for a Ca++-dependent exocytotic elimination of C5b-9 pores. Blood 1986, 68:556-561.
16. Hugel B., Socié G., Vu T., Toti F., Gluckman E., Freyssinet J.-M., et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999, 93:3451-3456.
17. Beyer-Enke S., Strauss L., Georgi M. Changes of serum complement concentrations in tumour patients prior and after radiotherapy. Strahlenther Onkol 1986, 162:441-447.
18. Kolev M., Towner L., Donev R. Complement in cancer and cancer immunotherapy. Arch Immunol Ther Exp (Warsz) 2011, 59:407-419.
19. Schneider S., Nuschele S., Wixforth A., Gorzelanny C., Alexander-Katz A., Netz R., et al. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. PNAS 2007, 104:7899-7903.
20. Kwaan H.C., Gordon L.I. Thrombotic microangiopathy in the cancer patient. Acta Haematol 2000, 106:52-56.
21. Bassé F., Gaffet P., Bienvenüe A. Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: are vesicles shed by filopod fragmentation?. Biochim Biophys Acta 1994, 1190:217-224.
22. Storr S.J., Carragher N.O., Frame M.C., Parr T., Martin S.G. The calpain system and cancer. Nat Rev Cancer 2011, 11:364-374.
23. Burnouf T., Goubran H.A., Chou M.L., Devos D., Radosevic M. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev 2014, 28:155-166.
24. Nomura S. Function and clinical significance of platelet-derived microparticles. Int J Hematol 2001, 74:397-404.
25. Comfurius P., Senden J.M., Tilly R.H., Schroit A.J., Bevers E.M., Zwaal R.F. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta 1990, 1026:153-160.
26. Harrison P., Cramer E.M. Platelet alpha-granules. Blood Rev 1993, 7:52-62.
27. Goubran H.A., Stakiw J., Radosevic M., Burnouf T. Platelet-cancer interactions 2014, 296-305. Seminars in thrombosis and hemostasis.
28. Gay L.J., Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer 2011, 11:123-134.
29. Goubran H.A., Kotb R.R., Stakiw J., Emara M.E., Burnouf T. Regulation of tumor growth and metastasis: the role of tumor microenvironment. Cancer Growth Metastasis 2014, 7:9.
30. Coupland L.A., Chong B.H., Parish C.R. Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells. Cancer Res 2012, 72:4662-4671.
31. Chen M., Geng J.-G. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp (Warsz) 2006, 54:75-84.
32. Placke T., Örgel M., Schaller M., Jung G., Rammensee H.-G., Kopp H.-G., et al. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res 2012, 72:440-448.
33. Placke T., Kopp H.-G., Salih H.R. The wolf in sheep's clothing: Platelet-derived "pseudo self" impairs cancer cell "missing self" recognition by NK cells. Oncoimmunology 2012, 1:557-559.
34. Chaffer C.L., Weinberg R.A. A perspective on cancer cell metastasis. Science 2011, 331:1559-1564.
35. Nurden A.T., Nurden P., Sanchez M., Andia I., Anitua E. Platelets and wound healing. Front Biosci 2007, 13:3532-3548.
36. Freyssinet J.M. Cellular microparticles: what are they bad or good for?. J Thromb Haemost 2003, 1:1655-1662.
37. Goubran H.A., Stakiw J., Radosevic M., Burnouf T. Platelets effects on tumor growth 2014, 359-369. Seminars in oncology: Elsevier.
38. Aatonen M., Grönholm M., Siljander P. Platelet-derived microvesicles: multitalented participants in intercellular communication 2012, 102-113. Seminars in thrombosis and hemostasis.
39. Campello E., Spiezia L., Radu C.M., Bulato C., Castelli M., Gavasso S., et al. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Thromb Res 2011, 127:473-477.
40. Hayon Y., Dashevsky O., Shai E., Brill A., Varon D., Leker R.R. Platelet microparticles induce angiogenesis and neurogenesis after cerebral ischemia. Curr Neurovasc Res 2012, 9:185-192.
41. Rumjahn S., Javed M., Wong N., Law W., Buxton I. Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase. Br J Cancer 2007, 97:1372-1380.
42. Janowska-Wieczorek A., Wysoczynski M., Kijowski J., Marquez-Curtis L., Machalinski B., Ratajczak J., et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 2005, 113:752-760.
43. Toth B., Liebhardt S., Steinig K., Ditsch N., Rank A., Bauerfeind I., et al. Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost 2008, 100:663-669.
44. Helley D., Banu E., Bouziane A., Banu A., Scotte F., Fischer A.-M., et al. Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. Eur Urol 2009, 56:479-485.
45. Montoro-García S., Shantsila E., Hernández-Romero D., Jover E., Valdés M., Marín F., et al. Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin. Br J Haematol 2014, 166:571-580.
46. Stanger B.Z., Kahn M.L. Platelets and tumor cells: a new form of border control. Cancer Cell 2013, 24:9-11.
47. Varon D., Hayon Y., Dashevsky O., Shai E. Involvement of platelet derived microparticles in tumor metastasis and tissue regeneration. Thromb Res 2012, 130:S98-9.
48. Falanga A., Tartari C.J., Marchetti M. Microparticles in tumor progression. Thromb Res 2012, 129:S132-6.
49. Robert S., Poncelet P., Lacroix R., Arnaud L., Giraudo L., Hauchard A., et al. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?. J Thromb Haemost 2009, 7:190-197.
50. Yuana Y., Oosterkamp T., Bahatyrova S., Ashcroft B., Garcia Rodriguez P., Bertina R., et al. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemost 2010, 8:315-323.
51. Zwicker J.I., Lacroix R., Dignat-George F., Furie B.C., Furie B. Measurement of platelet microparticles 2012, 127-139. Platelets and Megakaryocytes: Springer.
52. Lacroix R., Robert S., Poncelet P., Kasthuri R.S., Key N.S., Dignat-George F., et al. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2010, 8:2571-2574.
53. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010, 11:889-896.
54. Luan H., Ye F., Wu L., Zhou Y., Jiang J. Perioperative blood transfusion adversely affects prognosis after resection of lung cancer: a systematic review and a meta-analysis. BMC Surg 2014, 14:34.
55. Wang T., Luo L., Huang H., Yu J., Pan C., Cai X., et al. Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer. Ann Thorac Surg 2014, 97:1827-1837.
56. Burnouf T., Chou M.L., Goubran H.A., Cognasse F., Garaud O., Seghatchian J. A concise review on the role of microparticles/ microvesicles in blood components: are they clinically beneficial or harmful?. Transfus Apher Sci 2015, 53(2):137-145.
57. Cognasse F., Hamzeh-Cognasse H., Laradi S., Chou M.L., Seghatchian J., Burnouf T., et al. The role of microparticles in inflammation and transfusion: a concise review. Transfus Apher Sci 2015, 53(2):159-167.
58. Chou M.L., Lin L.T., Devos D., Burnouf T. Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment. Transfusion 2015, 55(10):2433-2444. 10.1111/trf.13162.
59. Goubran H.A., Burnouf T., Stakiw J., Seghatchian J. Platelet microparticle: a sensitive physiological "fine tuning" balancing factor in health and disease. Transfus Apher Sci 2015, 52:12-18.